U.S. Stem Cell Statistics

Total Valuation

U.S. Stem Cell has a market cap or net worth of $64,151.

Market Cap	64,151
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

U.S. Stem Cell has 641.51 million shares outstanding.

Shares Outstanding	641.51M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	10.95%
Owned by Institutions (%)	n/a
Float	563.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.21
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.29
Inventory Turnover	n/a

Taxes

In the past 12 months, U.S. Stem Cell has paid $695 in taxes.

Income Tax	695
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -95.83% in the last 52 weeks. The beta is -34.07, so U.S. Stem Cell's price volatility has been lower than the market average.

Beta (5Y)	-34.07
52-Week Price Change	-95.83%
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	40.42
Average Volume (20 Days)	131,655

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.06

Income Statement

In the last 12 months, U.S. Stem Cell had revenue of $19,974 and -$567,311 in losses. Loss per share was -$0.00.

Revenue	19,974
Gross Profit	15,053
Operating Income	-374,223
Pretax Income	-566,616
Net Income	-567,311
EBITDA	-374,918
EBIT	-567,347
Loss Per Share	-$0.00

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	n/a
Book Value Per Share	n/a
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	-43,065
Capital Expenditures	n/a
Free Cash Flow	-43,065
FCF Per Share	-$0.00

Full Cash Flow Statement

Margins

Gross margin is 75.36%, with operating and profit margins of -1,873.55% and -2,840.25%.

Gross Margin	75.36%
Operating Margin	-1,873.55%
Pretax Margin	-2,836.77%
Profit Margin	-2,840.25%
EBITDA Margin	-1,877.03%
EBIT Margin	-2,840.43%
FCF Margin	-215.61%

Dividends & Yields

U.S. Stem Cell does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-884.34%
FCF Yield	-67.13%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on November 4, 2015. It was a reverse split with a ratio of 1:1000.

Last Split Date	Nov 4, 2015
Split Type	Reverse
Split Ratio	1:1000

Scores

Altman Z-Score	n/a
Piotroski F-Score	2